ABSTRACT
Aim & Objectives The aim of the present study is to evaluate the regeneration efficacy of rhEGF impregnated in collagen membrane for the management of Millers class I & class II gingival recession defects.
Patients and methods 18 patients with 30 Millers class I & class II gingival recession defects were treated with one of the following interventions and randomly allocated into each of the following experimental groups; Test group: rhEGF impregnated in collagen membrane, Control group: plain collagen membrane. Clinical measurements at baseline, 3 months and 6 months included decreased probing depth, recession depth and increase in width of keratinized gingiva.
Results There was an improvement in tissue biotype in test group and statistically significant increase in KGW from baseline to 3 months which remained constant from 3 months to 6 months(p≤0.001) in both the groups. Similarly, RD shows constant increase from baseline to 6 months in test group whereas there is reduction in control group (p≤0.003). There was significant difference in clinical parameters in both test and control groups. All the patients had an uneventful healing phase.
Conclusion The beneficial effects of rhEGF resulted in healthy wound healing process with less scarring offers more potential properties showed promising results over collagen membrane. Further larger samples are required to confirm the efficacy of rhEGF in root coverage for soft tissue regeneration.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04375618
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Ethics Commitee, SVS Institute of Dental Sciences, Mahabubnagar, Telangana, India
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
viswachandra{at}hotmail.com (Ph no.9908183071)
bindu.sushmitha{at}gmail.com (Ph no.9490793546)
amarendhar{at}yahoo.com (Ph no.9885058679)
Data Availability
All data produced in the present work are contained in the manuscript
